Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe revision label was updated from v3.6.4 to v3.6.5, indicating a newer version of the study record. This change represents an update to the document version rather than substantive content changes.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics) as new metadata entries. Updated the revision tag from v3.6.3 to v3.6.4.SummaryDifference0.2%

- Check43 days agoChange DetectedRemoves the melanoma reference from the study page’s content. Eliminates the Related topics section, including the MedlinePlus Genetics link.SummaryDifference0.2%

- Check50 days agoChange DetectedNew related topics 'Melanoma' and 'MedlinePlus Genetics' were added, and the revision tag was updated from v3.6.2 to v3.6.3.SummaryDifference0.3%

- Check57 days agoChange DetectedThe page's revision metadata was updated from v3.6.0 to v3.6.2, indicating an updated release of the document.SummaryDifference0.1%

- Check71 days agoChange DetectedAdds a recruitment status notice and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the Intervention/Treatment label, reflecting a UI/structure change to the page.SummaryDifference0.7%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.